South Wales, Oct. 9 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "Novarrow" on Sept. 21. The details about the trademark application no. UK00004448658 published in the journal no. 2026/041 (Oct. 9).
With Basck Limited as representative, Maxim Rossmann filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Therapeutic pharmaceutical preparations; Medicinal preparations for the treatment and prevention of diseases and medical conditions; Gene therapy preparations for medical purposes; Cell therapy preparations for medical purposes; Pharmaceutical and biological preparations for clinical and therapeutic use; Biological preparations for the treatment of genetic disorders; Personalised therapeutic preparations for medical use; Pharmaceutical and biological preparations for the treatment of rare diseases; Small molecule pharmaceutical preparations; Pharmaceutical preparations for the treatment of Shwachman-Diamond syndrome; Biological preparations for the treatment of Shwachman-Diamond syndrome.
Class 42 : Consultancy relating to research and development in the field of therapeutics; Non downloadable software for drug development; SaaS for research and development; Artificial Intelligence solutions drug development; Medical and pharmaceutical research; Biotechnology research; Biological research; Biomedical research services; Scientific research relating to therapeutics, pharmaceuticals, biologics, cell therapies, and gene therapies; Drug discovery services; Pharmaceutical research and development; Research and development of pharmaceutical preparations; Research and development of biological preparations for medical use; Clinical research services; Clinical trial design, management, monitoring, and analysis; Conducting scientific studies and clinical studies; Laboratory research services; Laboratory testing services; Scientific testing and analysis services; Scientific investigations for medical and pharmaceutical purposes; Development of therapeutic products and treatment technologies; Research relating to genetics, genomics, proteomics, molecular biology, and bioinformatics; Cell engineering research; Gene editing research; Development and testing of cell therapies and gene therapies; Research in the field of personalised medicine and precision medicine; Scientific analysis and data analysis services; Research and development in the field of medicinal chemistry; Research and development in the field of structural biology; Scientific research in the field of structural biology; Scientific research relating to rare diseases; Scientific research relating to Shwachman-Diamond syndrome; Preclinical research and testing; Clinical trial planning and consultancy.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004448658
Disclaimer: Curated by HT Syndication.
